Posts

Showing posts from November, 2025

Fructooligosaccharides Market Analysis, Growth, Survey Report 2032 | Emergen Research

Image
  The market for fructooligosaccharides (FOS), which had a value of $2.59 billion in 2021, is anticipated to grow at a rate of 10.4% during the forecast period. Increased demand for low-calorie sweeteners and rising consumption of functional foods are the main drivers of market revenue growth. Due to their potential as prebiotics, fructooligosaccharides (FOS), which have long been used as sweeteners, are currently becoming more popular. For instance, the demand for low- or no-sugar choices is anticipated to increase as people try to limit or avoid sugar. According to study, over 60% of U.S. consumers want the market to offer more sugar-free chocolate options in order to cater to the growing number of health-conscious consumers. North America will experience the most rise in non-nutritive sweeteners in beverages in 2022, at 119%. With 48 million Americans 65 and older and 109 million Americans aged 50 or older, lifestyle concerns and ageing conditions are gradually driving functiona...

Multi Cancer Early Detection Market Revenue Poised for Significant Growth During the Forecast Period of 2022 - 2032 | Emergen Research

Image
  The latest research report by Emergen research named ‘ Global Multi Cancer Early Detection market   - Forecast to 2030’, entails a comprehensive review of the global Multi Cancer Early Detection market’s present and future trends. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. The study is inclusive of a profound analysis of this business sphere focuses on the overall remuneration of the market over the projected period. The global MCED market size was USD 791.6 Million in 2021 and is expected to register a revenue CAGR of 15.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer and extensive R&D for development of MCED are major factors driving market revenue growth. With increasing prevalence of cancer, early cancer detection is crucial, ...